These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7667377)

  • 1. Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety.
    Wilson AL; Langley LK; Monley J; Bauer T; Rottunda S; McFalls E; Kovera C; McCarten JR
    Pharmacol Biochem Behav; 1995; 51(2-3):509-14. PubMed ID: 7667377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease.
    Snaedal J; Johannesson T; Jonsson JE; Gylfadottir G
    Dementia; 1996; 7(1):47-52. PubMed ID: 8788082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease.
    White HK; Levin ED
    Psychopharmacology (Berl); 1999 Apr; 143(2):158-65. PubMed ID: 10326778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous nicotine in Alzheimer's disease: a pilot study.
    Newhouse PA; Sunderland T; Tariot PN; Blumhardt CL; Weingartner H; Mellow A; Murphy DL
    Psychopharmacology (Berl); 1988; 95(2):171-5. PubMed ID: 3137593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of nicotine on Alzheimer's disease patients.
    López-Arrieta JM; Rodríguez JL; Sanz F
    Cochrane Database Syst Rev; 2001; (2):CD001749. PubMed ID: 11406005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study.
    Parks RW; Becker RE; Rippey RF; Gilbert DG; Matthews JR; Kabatay E; Young CS; Vohs C; Danz V; Keim P; Collins GT; Zigler SS; Urycki PG
    Neuropsychol Rev; 1996 Jun; 6(2):61-79. PubMed ID: 8976498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
    Antuono PG
    Arch Intern Med; 1995 Sep; 155(16):1766-72. PubMed ID: 7654110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
    Rangani RJ; Upadhya MA; Nakhate KT; Kokare DM; Subhedar NK
    Peptides; 2012 Feb; 33(2):317-28. PubMed ID: 22266216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine for Alzheimer's disease.
    López-Arrieta JM; Rodríguez JL; Sanz F
    Cochrane Database Syst Rev; 2000; 2001(2):CD001749. PubMed ID: 10796667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
    Craft S; Claxton A; Baker LD; Hanson AJ; Cholerton B; Trittschuh EH; Dahl D; Caulder E; Neth B; Montine TJ; Jung Y; Maldjian J; Whitlow C; Friedman S
    J Alzheimers Dis; 2017; 57(4):1325-1334. PubMed ID: 28372335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementia.
    Moré MI; Freitas U; Rutenberg D
    Adv Ther; 2014 Dec; 31(12):1247-62. PubMed ID: 25414047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease.
    Potter A; Corwin J; Lang J; Piasecki M; Lenox R; Newhouse PA
    Psychopharmacology (Berl); 1999 Mar; 142(4):334-42. PubMed ID: 10229057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
    Potter AS; Newhouse PA
    Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment.
    White HK; Levin ED
    Psychopharmacology (Berl); 2004 Feb; 171(4):465-71. PubMed ID: 14534771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: an event-related potential study.
    Engeland C; Mahoney C; Mohr E; Ilivitsky V; Knott VJ
    Pharmacol Biochem Behav; 2002 May; 72(1-2):457-64. PubMed ID: 11900820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.
    Levin ED; McClernon FJ; Rezvani AH
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):523-39. PubMed ID: 16220335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
    Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.
    Tsai GE; Falk WE; Gunther J; Coyle JT
    Am J Psychiatry; 1999 Mar; 156(3):467-9. PubMed ID: 10080566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21.
    Arendash GW; Sengstock GJ; Sanberg PR; Kem WR
    Brain Res; 1995 Mar; 674(2):252-9. PubMed ID: 7796104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.